title: Human vaccines & immunotherapeutics: news.
abstract: Recent advances in the development of immunotherapeutic mAbs for cancer New vaccine reduces malaria infection by 72% Bavarian Nordic's cancer immunotherapy shows promise in colorectal cancer Chinese HFMD vaccine shows high efficacy in Phase 3 Two-dose regimen of Merck's Gardasil looks effective Accelerating influenza vaccine development using synthetic biology A key role for gut microbes in vaccination Understanding of and attitudes towards vaccines: a study in teenagers.
authors.affiliation: Acquisitions Editor; Landes Bioscience; Vienna, Austria.
authors.forename: Eva M
authors.initials: EM
authors.lastname: Riedmann
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D060890:B7-H1 Antigen / Q000276:immunology; D060908:CTLA-4 Antigen / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007252:Influenza Vaccines / Q000627:therapeutic use*; D008288:Malaria / Q000628:therapy*; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D060890:B7-H1 Antigen; C423236:CD274 protein, human; D060908:CTLA-4 Antigen; D019496:Cancer Vaccines; D007252:Influenza Vaccines; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor